Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1569 studies found for:    Lipid Storage Diseases
Show Display Options
RSS Create an RSS feed from your search for:
Lipid Storage Diseases
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)
Condition: Neutral Lipid Storage Disease
Intervention: Drug: Fibrate treatment
2 Unknown  Genetic Origin of Lipid Disorders
Condition: Lipid Disorder
Intervention:
3 Recruiting Genes Involved in Lipid Disorders
Condition: Dyslipidemia
Intervention:
4 Recruiting Biomarker for Gaucher Disease
Conditions: Lysosomal Storage Diseases;   Gaucher Disease;   Sphingolipidoses
Intervention:
5 Recruiting Natural History Study of Children With Metachromatic Leukodystrophy
Conditions: Leukodystrophy, Metachromatic;   Hereditary Central Nervous System Demyelinating Diseases;   Brain Diseases, Metabolic, Inborn;   Brain Diseases, Metabolic;   Brain Diseases;   Central Nervous System Diseases;   Nervous System Diseases;   Sulfatidosis;   Sphingolipidoses;   Lysosomal Storage Diseases, Nervous System;   Leukoencephalopathies;   Demyelinating Diseases;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Lipidoses;   Lipid Metabolism, Inborn Errors;   Lysosomal Storage Diseases;   Metabolic Diseases;   Lipid Metabolism Disorders
Intervention: Other: Natural History Study of Children With Metachromatic Leukodystrophy
6 Completed
Has Results
Lipid Management in Clinical Practice (MK-0524A-115)
Condition: Lipid Metabolism Disorder
Intervention:
7 Active, not recruiting Physical Activity and Nutrition in Children Study
Conditions: Overweight;   Glucose Metabolism Disorders;   Lipid Metabolism Disorders;   Blood Pressure;   Fitness
Intervention: Behavioral: lifestyle counseling
8 Recruiting MT2013-31:Allo BMT for Metabolic Disorders, Osteopetrosis and Males With Rett Syndrome
Conditions: Mucopolysaccharidosis I;   Mucopolysaccharidosis II;   Mucopolysaccharidosis VI;   Mucopolysaccharidosis VII;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Glycoprotein Metabolic Disorders;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Adrenoleukodystrophy;   Peroxisomal Disorders;   Osteopetrosis;   Rett Syndrome;   Sphingolipidosis;   Gangliosidosis;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann Pick B;   Niemann Pick C Subtype 2;   I-cell Disease
Interventions: Procedure: blood stem cell transplant;   Drug: Rabbit Anti-Thymocyte Globulin (ATG);   Drug: Fludarabine;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Cyclosporine A (CSA);   Drug: Methylprednisolone;   Drug: Mycophenolate Mofetil (MMF);   Drug: Granulocyte-Colony Stimulating Factor (G-CSF);   Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF);   Drug: N-acetylcysteine;   Drug: Celecoxib;   Drug: Vitamin E;   Drug: Alpha Lipoic Acid
9 Terminated
Has Results
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Conditions: Hurler's Syndrome;   Maroteaux-Lamy Syndrome;   Sly Syndrome;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Sphingolipidoses;   Krabbe Disease;   Wolman's Disease;   Niemann-Pick Disease Type B;   Niemann-Pick Disease, Type C
Interventions: Procedure: Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Campath-1H;   Drug: Busulfan
10 Completed Pharmacological Regulation of Fat Transport in Metabolic Syndrome
Conditions: Obesity;   Lipid Disorders;   Hypertriglyceridemia;   Cardiovascular Disease
Intervention: Drug: Atorvastatin and fenofibrate
11 Active, not recruiting Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)
Conditions: Obesity;   Disorder of Lipid Storage and Metabolism;   Lipid Metabolism Disorders;   Metabolic Disorder
Intervention: Behavioral: Exercise
12 Recruiting Effect of Age on Glucose and Lipid Metabolism
Conditions: Glucose Metabolism Disorders;   Lipid Metabolism Disorders;   Metabolic Diseases
Intervention: Behavioral: Aerobic Exercise
13 Completed
Has Results
Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Condition: Lipid Metabolism Disorders
Intervention: Drug: Fluvastatin sodium
14 Completed Omega 3 in Intervention Spinal Cord Injured People
Conditions: Lipid Metabolism Disorders;   Peroxidase; Defect
Interventions: Dietary Supplement: w3 supplement in SCI;   Other: placebo
15 Completed Stearidonic Acid and Lipid Metabolism
Condition: Lipid Metabolism Disorders
Interventions: Dietary Supplement: Echium oil (SDA-rich oil);   Dietary Supplement: high-oleic acid sunflower oil (HOSO) (low in SDA)
16 Active, not recruiting Study of the Long-term Effects of Exercise on Heath Indicators in Older People
Conditions: Hypertension With Complications and Secondary Hypertension;   Overweight and Obesity;   Lipid Metabolism Disorders;   Sarcopenia;   Osteoporosis;   Personal Satisfaction
Intervention: Behavioral: Exercise training
17 Completed Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis
Conditions: Lipid Metabolism Disorders;   Sterols;   Diet, High-Fat;   Cholesterol;   Fatty Acids;   Hyperlipidemias
Interventions: Behavioral: Changes in cholesterol metabolism;   Other: Lean red meat diet;   Other: Fat red meat diet
18 Completed Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia
Condition: Lipid Metabolism Disorder
Intervention: Drug: ezetimibe
19 Completed
Has Results
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Intervention: Drug: mipomersen sodium
20 Completed An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Intervention: Drug: Mipomersen Sodium

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years